{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:04:22Z","timestamp":1781193862867,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["RES0037745"],"award-info":[{"award-number":["RES0037745"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.plefa.2026.102733","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:13:53Z","timestamp":1772730833000},"page":"102733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor and red blood cell fatty acid composition as a potential indicator of outcomes in breast cancer: Findings from a retrospective cohort study"],"prefix":"10.1016","volume":"209","author":[{"given":"Jaqueline","family":"Munhoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Goruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Mazurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise G.","family":"Hemmings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-4767","authenticated-orcid":false,"given":"Catherine J.","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2026.102733_bib0002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41379-020-00704-7","article-title":"Prognostic and predictive parameters in breast pathology: a pathologist's primer","volume":"34","author":"Allison","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.plefa.2026.102733_bib0004","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Early Breast Cancer Trialists' Collaborative","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.plefa.2026.102733_bib0005","article-title":"Breast cancer prognostication and prediction: are we making progress?","volume":"18 Suppl 8","author":"Lonning","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.plefa.2026.102733_bib0006","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.3892\/ol.2016.5149","article-title":"Recent perspectives of breast cancer prognosis and predictive factors","volume":"12","author":"Cao","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.plefa.2026.102733_bib0007","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.ajpath.2021.02.006","article-title":"The tumor promotional role of adipocytes in the breast cancer microenvironment and macroenvironment","volume":"191","author":"Bernard","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.plefa.2026.102733_bib0008","doi-asserted-by":"crossref","first-page":"348","DOI":"10.31083\/j.fbl2812348","article-title":"Fatty acid metabolism: a new perspective in breast cancer precision therapy","volume":"28","author":"He","year":"2023","journal-title":"Front. Biosci. (Landmark. Ed)"},{"key":"10.1016\/j.plefa.2026.102733_bib0009","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/1541-7786.MCR-21-1069","article-title":"Monounsaturated fatty acids: key regulators of cell viability and intracellular signaling in cancer","volume":"20","author":"Scott","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.plefa.2026.102733_bib0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41586-021-04075-0","article-title":"Dietary palmitic acid promotes a prometastatic memory via Schwann cells","volume":"599","author":"Pascual","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2026.102733_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122770","article-title":"omega-3 long chain polyunsaturated fatty acids as sensitizing agents and multidrug resistance revertants in cancer therapy","volume":"18","author":"Corsetto","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plefa.2026.102733_bib0012","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1158\/0008-5472.CAN-09-3871","article-title":"De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation","volume":"70","author":"Rysman","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.plefa.2026.102733_bib0013","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1158\/0008-5472.CAN-15-1970","article-title":"Candidate antimetastasis drugs suppress the metastatic capacity of breast cancer cells by reducing membrane fluidity","volume":"76","author":"Zhao","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.plefa.2026.102733_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070948","article-title":"Stearoyl-CoA Desaturase 1 as a therapeutic target for the treatment of cancer","volume":"11","author":"Tracz-Gaszewska","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.plefa.2026.102733_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081784","article-title":"A critical review on the effect of docosahexaenoic acid (DHA) on cancer cell cycle progression","volume":"18","author":"Newell","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plefa.2026.102733_bib0016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.plefa.2026.102733_bib0017","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41419-024-07300-6","article-title":"Epoxy metabolites of linoleic acid promote the development of breast cancer via orchestrating PLEC\/NFkappaB1\/CXCL9-mediated tumor growth and metastasis","volume":"15","author":"Ni","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.plefa.2026.102733_bib0018","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/advances\/nmaa055","article-title":"Consumption of fish and omega-3 fatty acids and cancer risk: an umbrella review of meta-analyses of observational studies","volume":"11","author":"Lee","year":"2020","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.plefa.2026.102733_bib0019","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s11658-025-00694-x","article-title":"Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer","volume":"30","author":"Marchio","year":"2025","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.plefa.2026.102733_bib0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-019-05331-8","article-title":"Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts","volume":"177","author":"Newell","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.plefa.2026.102733_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109018","article-title":"Docosahexaenoic acid enrichment of tumor phospholipid membranes increases tumor necroptosis in mice bearing triple negative breast cancer patient-derived xenografts","volume":"107","author":"Newell","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.plefa.2026.102733_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092081","article-title":"Comparison of the utility of total plasma fatty acids versus those in cholesteryl ester, phospholipid, and triglyceride as biomarkers of fatty acid intake","volume":"11","author":"Furtado","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.plefa.2026.102733_bib0023","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj2530417","article-title":"Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane","volume":"253","author":"Field","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.plefa.2026.102733_bib0024","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biolog. Chem."},{"key":"10.1016\/j.plefa.2026.102733_bib0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.chroma.2013.01.094","article-title":"Direct quantification of fatty acids in human milk by gas chromatography","volume":"1284","author":"Cruz-Hernandez","year":"2013","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.plefa.2026.102733_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2022.102418","article-title":"Red blood cell fatty acid patterns from 7 countries: focus on the omega-3 index","volume":"179","author":"Schuchardt","year":"2022","journal-title":"Prostaglandins. Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2026.102733_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000513","article-title":"Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial","volume":"2","author":"Flock","year":"2013","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.plefa.2026.102733_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1476-511X-4-30","article-title":"Assessment of erythrocyte phospholipid fatty acid composition as a biomarker for dietary MUFA, PUFA or saturated fatty acid intake in a controlled cross-over intervention trial","volume":"4","author":"Poppitt","year":"2005","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.plefa.2026.102733_bib0029","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ajcn\/86.1.74","article-title":"Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women","volume":"86","author":"Sun","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2026.102733_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3945\/ajcn.110.005447","article-title":"Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study","volume":"93","author":"Kroger","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2026.102733_bib0031","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jamaoncol.2016.1897","article-title":"Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis","volume":"2","author":"Spring","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.plefa.2026.102733_bib0032","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3892\/ol.2024.14781","article-title":"Exploring lipidomic profiles and their correlation with hormone receptor and HER2 status in breast cancer","volume":"29","author":"Qian","year":"2025","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.plefa.2026.102733_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1199465","article-title":"Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature","volume":"14","author":"Shen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.plefa.2026.102733_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2019.102024","article-title":"Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasion","volume":"156","author":"Brown","year":"2020","journal-title":"Prostaglandins. Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2026.102733_bib0035","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1016\/j.febslet.2006.08.040","article-title":"A proposed model of fat packaging by exchangeable lipid droplet proteins","volume":"580","author":"Wolins","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.plefa.2026.102733_bib0036","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41419-020-2297-3","article-title":"Lipid droplets: platforms with multiple functions in cancer hallmarks","volume":"11","author":"Cruz","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.plefa.2026.102733_bib0037","first-page":"107","article-title":"Erythrocyte membrane fatty acid composition in cancer patients","volume":"23","author":"Mikirova","year":"2004","journal-title":"P. R. Health Sci. J."},{"key":"10.1016\/j.plefa.2026.102733_bib0038","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1309\/AJCP1QUQQLLT8BLI","article-title":"Erythrocyte fatty acids as potential biomarkers in the diagnosis of advanced lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer","volume":"142","author":"de Castro","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.plefa.2026.102733_bib0039","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/bjc.1991.73","article-title":"Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer","volume":"63","author":"McClinton","year":"1991","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.plefa.2026.102733_bib0040","first-page":"7","article-title":"Immunomodulatory effects of omega-3 fatty acids in patients with differentiated thyroid cancer before or after radioiodine ablation","volume":"19","author":"Amirkhani","year":"2022","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.plefa.2026.102733_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02269-0","article-title":"Depletion of essential fatty acids in muscle is associated with shorter survival of cancer patients undergoing surgery-preliminary report","volume":"11","author":"Bhullar","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.plefa.2026.102733_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2025.110025","article-title":"The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial","author":"Munhoz","year":"2025","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.plefa.2026.102733_bib0043","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.35517","article-title":"Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: findings from the phase II, double-blind, randomized controlled DHA-WIN trial","author":"Munhoz","year":"2025","journal-title":"Int. J. Cancer"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:51:24Z","timestamp":1781193084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327826000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S0952327826000116"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102733","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor and red blood cell fatty acid composition as a potential indicator of outcomes in breast cancer: Findings from a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102733"}}